Multidisciplinary Cancer Conferences for Gastrointestinal Malignancies Result in Measureable Treatment Changes: A Prospective Study of 149 Consecutive Patients

Abstract

Background In most jurisdictions, a minority of patients are discussed at multidisciplinary cancer conference (MCC) despite recommendations for such reviews. We assessed the impact of MCC review of gastrointestinal (GI) cancers at a stand-alone cancer center. Methods Patient data were prospectively collected on consecutive cases presented at a GI MCC during a 6-month period. Original treatment plans were collected confidentially before presentation and compared to post-MCC treatment plans. We defined changes in management plans as major (change in treatment modality) or minor (testing prior to original plan). Results A total of 149 cases were evaluated: 115 upper GI (gastric/small bowel—10 %, liver—32 %, pancreaticobiliary— 36 %), and 34 lower GI (23 %). Reasons for presentation were: questions regarding progression/metastases (44 %), management (26 %), diagnosis (21 %), pathology (15 %), and resectability (7 %). Physicians were certain of their original plans being the final recommendations in 84 % (n = 125). Change in management was recommended in 36 %; 72 % were major and 28 % were minor. Patients underwent all recommended treatments at our institution in 77 % of cases, a portion in 5 %, and no recommended treatments in 18 %. On multivariate analysis, physician degree of certainty for original management plan was not predictive of a change in management plan (p = 0.61). Conclusions Although certainty of prediscussion treatment plan is high, changes in treatment recommendations occurred in more than one-third of patients after GI MCC. This prospective study demonstrates the value of MCC in GI cancer sites, even at a stand-alone cancer center.

Collaborative Case Conferences in Rectal Cancer: Case Series in a Tertiary Care Centre

“…First, it was conducted in a single institution, and results might not be generalizable to other hospitals and geographic areas. However, we reported similar results in a study involving surgeons from all 11 lhin4 hospitals, as did a study at the Roswell Park Cancer Institute involving surgeons participating in a gastrointestinal mcc 13 . Our results are also in line with those of a systematic review of mccs 6 .…”

Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus

“…Results from a first prospective study to evaluate the MDT discussion process and its effects on treatment approaches for a variety of gastrointestinal cancers at a US cancer centre have recently been published [99]. Despite 84% of clinicians being certain of their original plan, a change was recommended in 36% of cases, 72% of which involved major changes; there was 77% adherence to the recommended treatments.…”

Colorectal cancer in South Africa: An assessment of disease presentation, treatment pathways and 5-year survival

“…A prospective study of an MDT showed that despite 84% of clinicians being certain of their management plan, following the MDT discussion 36% changed their management plan; 72% of these changes were major ones. [22] Furthermore, studies have shown lower survival rates following non-adherence to MDT decisions. [23] Finally, a national CRC registry should be established so that understanding of disease epidemiology, presentation, outcomes and therapeutic resources can be improved.…”